Myeloablative allogeneic stem cell transplantation for lymphoblastic lymphoma in Sweden: A retrospective study
✍ Scribed by Vladimir Lj Lazarevic; Mats Remberger; Hans Hägglund; Helene Hallböök; Gunnar Juliusson; Eva Kimby; Claes Malm; Anders Wahlin; Hamdy Omar; Jan-Erik Johansson
- Publisher
- John Wiley and Sons
- Year
- 2011
- Tongue
- English
- Weight
- 681 KB
- Volume
- 86
- Category
- Article
- ISSN
- 0361-8609
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract We report a patient with a relapsed in bone marrow of extremities after allogeneic peripheral blood stem cell transplantation for acute lymphoblastic leukemia (ALL). The patient complained of pain in the right upper arm and left leg 15 months after transplantation. Magnetic resonance im
## Abstract To circumvent the cardiac toxicity of high‐dose cyclophosphamide (CY) in the myeloablative conditioning for those with cardiac comorbidity, we developed a new cardiac sparing conditioning regimen (VP/rCY/TBI) composed of 12 Gy of total body irradiation (TBI), etoposide (VP‐16) (40 mg/kg
## Abstract ## BACKGROUND The immune‐mediated graft‐versus‐tumor (GVT) effect plays a therapeutic role in the treatment of patients with hematologic malignancies who undergo allogeneic hematopoietic stem cell transplantation (HSCT). More recently, it was reported that a GVT effect also occurred in